ClinicalTrials.gg
Not yet recruitingNCT07800611HB PhUpdated Sep 2, 2026

Pharmacist Led Intervention in the Management of Anemia Among Pregnant Woman

An interventional study of Pharmacist-led counseling on anemia management in Anemia Complicating Pregnancy, sponsored by Hamdard University. Not yet recruiting at 1 site in Pakistan. Open to female participants. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Hamdard University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Sex
Female
01

Study summary

Anemia is a major public health problem among pregnant women, particularly in low- and middle-income countries. It is characterized by a reduction in hemoglobin concentration or the oxygen-carrying capacity of the blood, which may be insufficient to meet the physiological needs of the body. Maternal anemia is associated with an increased risk of adverse maternal and fetal outcomes.

Despite the high prevalence of anemia among pregnant women, poor medication adherence and inadequate understanding of prescribed therapy may limit treatment effectiveness. Pharmacists can play an important role in providing medication-related education, improving patients' understanding of their treatment, identifying barriers to adherence, and promoting appropriate medication use. However, evidence on pharmacist-led educational interventions to improve medication adherence and hemoglobin levels among anemic pregnant women in Pakistan remains limited.

Therefore, this randomized controlled trial will be conducted to evaluate the effect of a structured pharmacist-led educational intervention on medication adherence and hemoglobin levels among anemic pregnant women in District Chakwal, Punjab, Pakistan.

A total of 100 eligible pregnant women diagnosed with anemia will be recruited and randomly allocated into intervention and control groups. Participants in the intervention group will receive a structured pharmacist-led educational intervention in addition to routine care, while participants in the control group will receive routine antenatal care and standard anemia management.

Medication adherence and hemoglobin levels will be assessed at baseline and after the intervention. The study will determine whether pharmacist-led educational counseling improves medication adherence and hemoglobin levels compared with routine care.

Data will be analyzed using IBM SPSS Statistics version 26. A paired-sample t-test will be used to compare changes in continuous variables, particularly hemoglobin levels, between baseline and post-intervention assessments. McNemar's test will be used to assess changes in paired categorical variables, including medication adherence where appropriate. A p-value of \<0.05 will be considered statistically significant.

02

Conditions studied

  • Anemia Complicating Pregnancy

Browse trials for

Keywords

  • Anemia
  • Pharmacist
  • intervention
03

In context

Anemia

1,810 studies on the registry are indexed under Anemia; 215 are open to participants now.

This study's planned enrollment of 100 is below the median of 117 across 1,336 interventional studies indexed under Anemia.

Browse Anemia studies →

Lead sponsor

Hamdard University is the lead sponsor of 19 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Pregnant woman
  2. \<11g/dl
  3. Having Punjab domicile-

Exclusion criteria

Exclusion Criteria:

  1. Patients with co-morbidities
  2. Patients with >11g/dl
  3. Outside the Punjab domicile
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Other
    Pre and post evaluation

    Pharmacist-Led Anemia Counseling: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up. Study Design: Single-arm, pre-post evaluation.

    Other: Pharmacist-led counseling on anemia management

Interventions

  • OtherPharmacist-led counseling on anemia management

    Intervention Description: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up. Study Design: Single-arm, pre-post evaluation.

    Also known as: Pharmacist-Led Anemia Counseling

06

What researchers measure

Primary outcomes

  1. Change in hemoglobin concentration

    Description: Change in hemoglobin (Hb) concentration from baseline to one-month follow-up, measured in g/dL using a laboratory hemoglobin test.

    Time frame: Baseline and one month after the pharmacist-led counseling intervention.

  2. Change in anemia severity

    Description: Change in anemia severity from baseline to one-month follow-up, categorized according to the participant's measured hemoglobin concentration using the predefined diagnostic criteria for anemia.

    Time frame: Baseline and one month after the pharmacist-led counseling intervention.

  3. Medication adherence

    Description: Change in medication adherence from baseline to one-month follow-up, assessed using the \[name of your actual validated adherence scale/questionnaire\].

    Time frame: Time Frame: Baseline and one month after the intervention.

07

Study locations

1 site
  • DHQ Chakwal
    Islamabad, Islamabad 45570, Pakistan
08

References and documents

Publications

  • Adje, D., et al. (2020). "Impact of pharmacists' health educational intervention on anemia in pregnancy in rural settings in Kano, Nigeria." Int. J. Pharm. Sci. Res 11: 2403-2410.

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07800611
Lead sponsor
Hamdard University
Responsible party
Muhammad Abubakar (Associate Professor, Hamdard University) — Principal investigator
First posted
Sep 2, 2026
Start date
Sep 10, 2026 (estimated)
Primary completion
Oct 15, 2026 (estimated)
Completion
Nov 15, 2026 (estimated)
Last update
Sep 2, 2026

Study contacts

Muhammad Abubakar, PhD
Contact
mabubakar.pharmacist@gmail.com
00923237166544

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion